Rahman MA, Ahmed MA, Akter S, Nasrin P, Islam IA, Akhter N, R. Kabir MM, Poddar SC, H. Masud MA, Shah MS. Assessment of measurable residual disease after induction chemotherapy in acute lymphoblastic leukemia patients in a tertiary care hospital. Int J Adv Med [Internet]. 2024 Aug. 27 [cited 2025 Oct. 13];11(5):428-33. Available from: https://www.ijmedicine.com/index.php/ijam/article/view/4054